Takeda Names US Head


From DCAT Value Chain Insights (VCI)

By People On The Move posted 04-14-2015 11:48

  

Takeda Pharmaceutical Company Limited and Takeda’s wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. have named Ramona Sequeira as TPUSA as president of the US Business Unit. In this role, Sequeira will lead all business operations for the US and will report to Christopher Weber, president and chief executive officer of Takeda.

Sequeira bringseadership experience across multiple therapy areas including neuroscience, specialty and primary care, and several regions, including the US, Canada, and the UK. Her most recent role was as vice president, Lilly USA at Eli Lilly and Company. Previous to that, she was the general manager of Lilly’s UK Hub.

Source: Takeda Pharmaceuticals U.S.A.

0 comments
30 views


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription 

Permalink